Skip Ribbon Commands
Skip to main content
CIBMTR

Study Lists

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   /   Studies   /   Clinical Outcomes Research   /   Study Lists   /   Observational Studies
  • Print
  • Share

 


Lymphoma Working Committee Studies

The Lymphoma Working Committee provides scientific oversight for studies related to hematopoietic cell transplantation for Hodgkin and non-Hodgkin disease. Studies related to cellular therapy evaluating lymphoma-specific questions or those aiming to compare cellular therapy approaches (e.g. CAR-T vs. autologous transplant) are also entertained in collaboration with the Cellular Immunotherapy for Cancer Working Committee.

Learn more about the studies conducted through the Lymphoma Working Committee using the links below.

Recently Completed Studies

NumberTitleStatus
LY20-G1 Guidelines for cellular therapy for mantle cell lymphoma. Published
LY20-01 Comparison of outcomes of diffuse large B-cell lymphoma patients with partial response after salvage therapy who underwent chimeric antigen receptor T versus autologous hematopoietic cell transplantation. Published
LY19-02 Determining the optimal conditioning regimen for patients with primary central nervous system lymphoma undergoing autologous hematopoietic cell transplantation. Published
LY19-01b Reduced-intensity vs. myeloablative conditioning for T-cell NHL patients undergoing allogeneic HCT. Published
LY19-01a Post-transplant cyclophosphamide-based haploidentical transplantation versus matched sibling or well matched unrelated donor transplantation for peripheral T-cell lymphoma: A CIBMTR lymphoma working committee and EBMT lymphoma working party analysis. Published
LY18-03 Transplantation for chronic lymphocytic leukemia undergoing richter�s transformation arising in the setting of indolent lymphoma. Published
LY18-02b Transplant utilization rates in mantle cell lymphoma. Published
LY18-02a Effect of time to relapse on overall survival in mantle cell lymphoma patients following frontline autologous stem cell transplant. Published
LY18-01e Outcomes of Autologous Hematopoietic Cell Transplantation (AHCT) in Elderly patients with Diffuse Large B Cell Lymphoma (DLBCL) Published
LY18-01d Autologous hematopoietic cell transplantation in diffuse large B-cell limphoma after 3 or more lines of prior therapy: evidence of durable benefit Published
LY18-01c Outcomes for resistant�autolous transplants in early chemotherapy failure�for diffuse large B-cell lymphoma patients. Published
LY18-01b Outcomes in B cell non-Hodgkin lymphoma patients who underwent autologous stem cell transplantation following rituximab containing conditioning regimens in partial remission. Published
LY18-01a Outcomes in B cell non-Hodgkin lymphoma patients who underwent autologous stem cell transplantation following rituximab containing conditioning regimens. Published
LY17-02d Conditioning regimen in allografts for diffuse large B cell lymphoma. Published
LY17-02c Conditioning regimen in allografts for diffuse large B cell lymphoma. Published
LY17-02b Allografts following reduced intensity conditioning for non-Hodgkin disease. Published
LY17-02a Allografts following reduced intensity conditioning. Published
LY17-01b Clinical outcomes of patients age ?65 undergoing allogeneic hematopoietic cell transplant for non-hodgkin lymphoma. Published

Last Updated: 10/22/2020 1:37 PM
CIBMTR